glp-1 prescriptions q1 2025 growth Obesity Market Patients Face New Barriers for

For those who want other choices for weight management, compounded semaglutide can be a good option

Wegovy is moving toward PBS coverage for a limited group of people with obesity plus established cardiovascular disease, but broad subsidy for obesity alone is not here yet

However, a long-term exploratory RCT in 150 people with obesity found that differences in eating disorders psychopathology scores were not maintained at 52 weeks when liraglutide in combination with behavioral therapy was compared with behavioral therapy alone 215

FDA Approves Lillys Foundayo (orforglipron), the Only GLP-1 Pill for Weight Loss That Can Be Taken Any Time of Day Without Food or Water Restrictions